Orthobiologics

Over 25,000 of Theracell's licensed demineralized bone fiber products have been delivered by the company's licensee partners....

The human extracellular matrix is slated to enter a Phase 1/2 Trial for knee cartilage regeneration in 1Q21....

FIBRI-CELL with Osteo-Spin offers a novel approach to enhance traditional bone graft substitutes for orthopedic fusion....

During its 10 years’ partnership with LAS Brasil, Graftys achieved the milestone of 10,000 units of GRAFTYS HBS sold in...

Analysis of more than 16,000 lumbar fusion procedures showed similar clinical outcomes with average hospital fees up to $50,000 lower...

TheraCell licensed the technology to AlloSource to market AlloFuse Cortical Fibers and AlloFuse Fiber Boats, and to produce private-label products....

MOTYS placental tissue particulate will be evaluated for safety and efficacy to treat osteoarthritis of the knee....

First patients completed 12-month follow-up in its prospective, multi-center study of ProChondrix CR to repair knee articular cartilage defects....

FIBRI-CELL with Osteo-Spin technology offers a novel approach to enhance traditional bone graft substitutes for orthopedic fusion procedures....

i-FACTOR+ Matrix is now fully available in Canada through distributor Surgi-One, and can be used in both spine and general...